Skip to Main Content

Advertisement

Umbrella Alt Text
Umbrella Alt Text Close
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Cancer Research Communications
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics
  • For Authors
    • Information for Authors
    • Author Services
    • Journal Awards
  • About Us
    • AACR Journals
    • Advertising
    • Permissions & Reprints
    • Subscriptions
    • Submit
  • Article Collections
    • Cancer Hallmarks Collection
    • Hot Topics
    • Towards Degrader-Antibody Conjugates
    • Advances in Tumor Immunology and Immunotherapy
    • Editors' Picks
    • COVID-19
  • Alerts
  • News
  • Cancer Hallmarks
  • Webinars
Search Dropdown Menu
header search
    Search
    Advanced Search
    User Tools Dropdown
    Register
    Sign In
    Cancer Research Communications
    Toggle MenuMenu
    • About
      • The Journal
      • The Editors
      • Editors' Corner Archive
      • AACR Journals
    • Journal Sections
      • Molecular and Cellular Biology
      • Tumor Biology
      • Immuno-oncology
      • Emerging Technologies and Data Science
      • Therapeutic Research and Development
      • Precision Medicine and Biomarkers
      • Clinical Research and Trials
      • Epidemiology and Prevention
      • Health Disparities and Outcomes Research
      • All articles
    • OnlineFirst
    • Journal Archive
    • For Authors
      • Information for Authors
      • Author Services
      • Outstanding Journal Article Award
      • Submit
    • Alerts
    • News
    Skip Nav Destination
    Update search
    Querybuilder input 1
    Filter All
    • All
    • Title
    • Author
    • Author Affiliations
    • Full Text
    • Abstract
    • Keyword
    • DOI
    • ISSN
    • EISSN
    • Issue
    • Volume
    • References
    Querybuilder input 2
    Filter All
    • All
    • Title
    • Author
    • Author Affiliations
    • Full Text
    • Abstract
    • Keyword
    • DOI
    • ISSN
    • EISSN
    • Issue
    • Volume
    • References
    Querybuilder input 3
    Filter All
    • All
    • Title
    • Author
    • Author Affiliations
    • Full Text
    • Abstract
    • Keyword
    • DOI
    • ISSN
    • EISSN
    • Issue
    • Volume
    • References
    Querybuilder input 4
    Filter All
    • All
    • Title
    • Author
    • Author Affiliations
    • Full Text
    • Abstract
    • Keyword
    • DOI
    • ISSN
    • EISSN
    • Issue
    • Volume
    • References
    Querybuilder input 5
    Filter All
    • All
    • Title
    • Author
    • Author Affiliations
    • Full Text
    • Abstract
    • Keyword
    • DOI
    • ISSN
    • EISSN
    • Issue
    • Volume
    • References
    Querybuilder input 6
    Filter All
    • All
    • Title
    • Author
    • Author Affiliations
    • Full Text
    • Abstract
    • Keyword
    • DOI
    • ISSN
    • EISSN
    • Issue
    • Volume
    • References

    NARROW

    Format
    Filter by format
    Subjects
    Filter by subjects
    Journal
    Filter by journal
    Article Type
    Filter by article-type
    Date
    Filter by date
    Apply
    Availability
    Availability
    1-1 of 1
    Vinay Puduvalli
    Close
    Save search
    Follow your search
    Access your saved searches in your account
    Would you like to receive an alert when new items match your search?
    Close Modal
    Sort by
    Journal Articles

    Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma

    Kristina Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott Boerner, Jing Li, Diane Durecki, Jan Drappatz, Vinay Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, S. Percy Ivy, Ranjit S. Bindra, Antonio Omuro, Patricia LoRusso
    Journal: Cancer Research Communications
    Cancer Research Communications (2023) 3 (2): 192–201.
    https://doi.org/10.1158/2767-9764.CRC-22-0436
    Published: 02 February 2023
    Abstract
    View article titled, Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <em>IDH1-</em> and <em>IDH2</em>-mutant Glioma
    Open the PDF for Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <em>IDH1-</em> and <em>IDH2</em>-mutant Glioma in another window
    Includes: Supplementary data

    Advertisement

    Email alerts

    eTOC Alert
    Close Modal
    Cancer Research Communications
    • Journal Archive
    • Journal Alerts
    • Info for Authors
    • Submit an Article
    • About the Journal
    • Editors
    • News
    • Twitter/X
    • Online ISSN 2767-9764

    AACR Journals

    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Cancer Research Communications
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

     

     

    • Information on Advertising & Reprints
    • Information for Institutions/Librarians
    • RSS Feeds
    • Privacy Policy
    • Twitter
    • LinkedIn
    • Facebook
    • Youtube
    • Copyright © 2025 by the American Association for Cancer Research.
    Close Modal
    Close Modal
    This Feature Is Available To Subscribers Only

    Sign In or Create an Account

    Close Modal
    Close Modal
    This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
    Accept